Case Report and Literature Review: Behçet's Disease With a Novel TFPI Gene Mutation

Jiewen Ma; Wengang Sun; Liang Tang; Di Yang

doi:10.3389/fmed.2022.873600

Case Report and Literature Review: Behçet's Disease With a Novel TFPI Gene Mutation

Front Med (Lausanne). 2022 Apr 19:9:873600. doi: 10.3389/fmed.2022.873600. eCollection 2022.

Authors

Jiewen Ma¹, Wengang Sun¹, Liang Tang¹, Di Yang¹

Affiliation

¹ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Abstract

We report a case of Behçet's disease (BD) with a newly identified tissue factor pathway inhibitor (TFPI) gene mutation. The patient suffered from recurrent deep vein thrombosis and dural sinus thrombosis which could not be relieved by constant anticoagulation therapy. Slight relapsing oral lesion was the initial manifestation of BD but was neglected. Genital ulcers and ocular symptoms were manifest 8-month later than vascular involvement. The patient was diagnosed with BD at last and a novel mutation in TFPI was identified simultaneously. After administration with azathioprine and dexamethasone, the clinical symptoms were quickly gone and no relapse was found during 7-month follow-up.

Keywords: Behçet’s disease; TFPI; case report; mutation; thrombosis.

Publication types

Case Reports